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Abstract Purpose Because of its afﬁnity for water-based tissues, carbon dioxide (CO2) laser has
become an instrument of choice for treating oral mucosa conditions, ranging from
inﬂammatory to malignant lesions. The aim of this work is to systematically evaluate
the outcomes of laser surgery over a wide range of lesions, while providing a solid and
reproducible protocol for CO2 laser surgery in the outpatient management of oral lesion.
Methods Seventy-eight patients underwent 92 laser outpatient procedures for
treatment of a wide range of benign and malignant lesions. We performed 60
removals, 11 exeretic biopsies, 15 vaporizations, and 3 vaporization/removal com-
bined. We analyzed laser parameters applied for each technique and provided a
systematic evaluation of surgical results.
Results No problems occurred intraoperatively in any of the patients. Five patients
complained marginal pain, while 3 patients had postsurgery bleeding. All treatments
were successful, with the notable exception of 3 relapsing verrucous proliferative
leukoplakias and an inﬁltrating squamous cell carcinoma of the tongue requiring
radicalization. We did not record any adverse reactions to drugs or lesions due to laser
action. Concordance between clinical diagnosis and pathology results was at 94.8%.
Conclusions Our data indicate that CO2 laser is a solid choice for outpatient
treatment of oral lesions. This technique grants painless and almost bloodless
treatment, with negligible recurrence rates. Providing a solid reference for laser
settings and operative techniques could provide a foundation for further exploring
this tool while offering the basis for a positive comparison between different surgical
techniques and options.
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Carbon dioxide (CO2) laser was the ﬁrst type of laser intro-
duced in medical treatments. Producing beams of light at a
10,600-nm wavelength, which are absorbed by water in the
tissue, it causes tissue hemostasis allowing excision of a large
variety of soft tissue lesions, as well as many other clinical
procedures.
It was invented in 1963 by Patel, then Ben-Bassat was the
ﬁrst to describe its use for intraoral treatment in 1984. Since
then, many studies have endorsed the advantages and effec-
tiveness of CO2 laser as treatment for oral (OLs), maxillofa-
cial, and cervical lesions.1
There are plenty of advantages of laser over cold steel
surgical procedures such as minimal postoperative swelling
and scarring. It also reduces bacterial contamination through
sterilization of the surgical site. Compared with other laser
types and to monopolar and bipolar cautery, it allows a
reduced mechanical and thermal damage with minimal post-
operativepain. It isbecominganestablishmentalso for itsanti-
inﬂammatory, biostimulant, and regenerative effects, permit-
ting excellent healing and lowmorbidity.2,3CO2 laser has been
comparedwithother nonsurgicalmethods likediode laser and
cryotherapy: CO2 and diode lasers have signiﬁcantly better
outcomes than cryosurgery in the management of oral leuko-
plakia in terms of pain, swelling, and slough formation.4
Because of its afﬁnity for water-based tissues, the CO2 laser
has become a favorite instrument of oral surgeons for treat-
ment of pathologic conditions of the oral mucosa. It has been
recommended to treat benign OLs, such as ﬁbromas, vascular
anomalies, mucoceles, ranulae, gingival hyperplasias with
different causes (idiopathic or due to side effects of medica-
tions), aphthous ulcers, mucosal frenula, or tongue ties (anky-
loglossia), as well as premalignant lesions such as oral
leukoplakia, erythroplakia, papillomas, and lichen planus.4–8
Some reports on the use of the CO2 laser also support the
possibility of treating malignant oral diseases in early stages
with excisional biopsies, as well as mucosal melanomas.2,9
Inour institution, CO2 laser is used for outpatient treatment
of a wide range of conditions: among benign lesions we adopt
this procedure for treating traumatic pseudoﬁbromas, scars,
ulcers (traumatic or as a residual of surgical removal), ﬁbro-
mas, andmucoceles. Other common practice is the excision of
potentially malignant neoformations like leukoplakias, pyo-
genic granulomas, papillomas, and actinic cheilitis. We also
manage in situ and minimally invasive malignancies.
In the literature, most of the studies describe the utiliza-
tion of CO2 laser for a single indication, over all for leukopla-
kia, but we lack papers methodologically exploring all
possible utilizations for soft oral tissues surgery and the
procedures to adopt in each singular occasion, especially
with relevant caseloads.3,5–7 This is peculiarly important if
we take into account that modern CO2 lasers usually are
equipped with software and beam scanners that allow not
only cutting, but also vaporization, which has a traditional
role in aesthetic skin treatments. Furthermore, current liter-
ature on the subject usually fails to provide methodological
instructions on these treatments, with sparse information on
scanning programs and laser power, thus making compari-
son between different techniques virtually impossible and
raising the learning curve for untrained surgeons. Therefore,
the aim of this work is to analyze a wide case series of
outpatient treated at our institution to summarize current
applications of these modern tools, while proposing valid
CO2 settings and procedural instructions granting efﬁcient
OL treatment with marginal complications.
Materials and Methods
The study has been designed as a retrospective review. Due to
its retrospective design, it was granted exemption from the
Institutional Review Board of ASST Santi Paolo e Carlo, Milan,
Italy. We reviewed charts from patients attending our oro-
pharyngeal pathology outpatient clinic to identify patients
who underwent laser surgery for oral cavity conditions from
June 2014 to May 2018. Inclusion criteria required outpa-
tients diagnosed with benign or potentially malignant oral
cavity lesions, CO2 laser outpatient treatment, and a mini-
mum age of 14 years old to ensure an acceptable compliance.
Patients with a follow-up period shorter than 30 days were
excluded from the study. Seventy-eight consecutive patients
were therefore identiﬁed. Patients’ demographics are shown
in ►Table 1. They underwent 92 laser procedures, either
lesion vaporization or removal; some patients receivedmore
treatments due to disease persistence, recurrences, or new
onset lesions. The procedures are detailed in ►Table 2.
All patientswere treatedwith a fractional CO2 laser (Lume-
nis Acupulse 30 ST, Lumenis Ltd, Yokneam, Israel) with a 125-
mmhandheld hand piece. Before any session of treatment, we
registered a video of the lesion to document presurgical status
of the pathology; an informed consent was obtained from the
patient or his/her caregivers (for patients aged 14–18 years)
prior to the treatments. After that, every procedure started
with a local anesthesia with either Carbocaine alone or Car-
bocainewith adrenaline (the former was used in patientswith
already diagnosed heart conditions). Laser settings vary from
removal to vaporization procedures; the former is performed
through a 4-W continuous beam with superpulsed emission,
with a 0.2 1mmsize,while the latter is performed through a
6-W superpulsed beam, with repeated emissions, with 0.49
seconds of range time between two consecutive pulses, a
square or round beam shape, with 3 to 5mm width, and 1
mm of depth (see ►Table 3). Our group performed, on 78
patients, 92 procedures: 71 cuttings, among which 63
Table 1 Analysis of patients’ demographics: age average,
standard deviation, and range are provided
Patients demographics Specifics Values
Age
Mean 56.7
Standard deviation 15.55
Range 14–83
Sex
Male 41
Female 37
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complete removals and 11 incisional biopsies, and 18 vapor-
izations (see ►Table 4). Removals and biopsies were sent for
surgical pathology examination, while vaporizations, which
do not allow for surgical pathology examination, were per-
formed only on patients with a conﬁrmed diagnosis of verru-
cous proliferative leukoplakia or hyperkeratotic lichen planus
oralis via prior punch biopsy. Leukoplakias were treated with
laser excision whenever we deemed a surgical pathology
examination useful for diagnosis (►Fig. 1), while we chose
to vaporize lesions whose histology had been already con-
ﬁrmedwith incisional biopsies no longer than 1month before
(►Fig. 2).
All patients were prescribed to apply during the following
2weeks two gels on the surgical site: a 0.5% chlorhexidine gel
and amino acid and hyaluronate gel. All patients were
prescribed to use acetaminophen 1 g every 6 hours in case
of mild to moderate pain. We attended outpatients for a
follow-up at 21 days after treatment with a recorded video of
the outcomes. All patients were instructed to contact our
clinic in case of bleeding, worsening swelling, numbness, or
intense/uncontrolled pain. Visual Analogue Scale (VAS) of
100mm in length was used to evaluate the intensity of pain.
This scale was converted into a numerical value: from 0
(corresponding to no pain) to 10 (unbearable pain). Each
patient marked the intensity of pain at 24 hours, 48 hours,
Table 2 Summary of surgical procedures considered in this
study
Procedures and clinical diagnosis N %
Traumatic pseudoﬁbroma removal 24 26.08
Papilloma removal 15 16.30
Leukoplakia removal 15 16.30
Verrucous proliferative
leukoplakia vaporization
14 15.21
Leukoplakia exeretic biopsy 9 9.78
Granuloma removal 4 4.34
Ulcer removal 3 3.26
Scar vaporization 2 2.17
Lichen planus vaporization 2 2.17
Minor salivary glands
mucocele removal
1 1.08
Leukoerythroplakia exeretic biopsy 1 1.08
Ulcer vaporization 1 1.08
Venous malformation removal 1 1.08
Total 92 100.00
Note: The condition treated is taken into account.
Table 3 Classiﬁcation of technique typologies
Type of procedure N %
Removal 63 68.54
Vaporization 18 20.22
Biopsy 11 11.24
Table 4 Areas of treatment
Site of treatment N of sessions %
Tongue 27 30.00
Papilloma 2
Cistoadenoma 1
Fibroma 9
Leukoplakia 13
Ulcer 4
Granuloma 3
Cheek 17 18.89
Leukoplakia 9
Fibroma 6
Granuloma 1
Papilloma 1
Hard palate 11 12.22
Leukoplakia 5
Papilloma 4
Fibroma 2
Gum 10 11.11
Leukoplakia 5
Fibroma 2
Papilloma 1
Venous-
arterious
malformation
1
Granuloma 1
Inferior lip 8 8.89
Fibroma 3
Scar 2
Leukoplakia 1
Papilloma 1
Mucocele 1
Soft palate 5 5.56
Papilloma 3
Leukoplakia 2
Retromolar trigone 3 3.33
Leukoplakia 3
Frenulum of tongue 3 3.33
Papilloma 3
Oral ﬂoor 3 3.33
Leukoplakia 2
Papilloma 1
Oral vestibule 2 2.22
Leukoplakia 1
Venous-
arterious
malformation
1
Superior lip 1 1.11
Papilloma 1
Total 90 100.00
Note: Several procedures developed on two or more zones.
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and then at 7 days postoperatively. To record healing time,
we gave patients instructions of recording how many days
after surgery the lesion healed.
We also analyzed clinical diagnosis divided by sites,
making an evaluation of prevalence of each lesion for area
of treatment. Finally, recurrences localization was
investigated.
Results
Noproblems occurred intraoperatively in anyof the patients,
and surgery was quickly and safely performed. No procedure
took longer than 10minutes. We had a negligible amount of
complications: four patients had postsurgery bleeding, only
two of them required cautery by bipolar forceps and one had
absorbable stitches. The team only registered three relapses
on verrucous proliferative leukoplakia: a wide recurrence
which required a removal in general anesthesia, and two
relapses at 6 and 24 months which respectively have been
managed with an additional vaporization and a new biopsy
with vaporization. A histological result of inﬁltrating squa-
mous cell carcinoma of the tongue needed a radicalization
through a following excision in general anesthesia associated
with neck dissection. We did not record any adverse reac-
tions to drugs or lesions due to laser action. Furthermore,
laser CO2 seems a painless surgery due to the fact thatmost of
the patients recorded a low pain level, with a mean of 2.5 on
VAS scale after 24 hours and standard deviation of 1.78, a
value of 2 after 48 hours with a standard deviation of 1.33,
and 0 points 7 days after surgery. Only 2 patients differed
from those estimates with a higher level of discomfort
respectively at 8 and 7 points on VAS scale at 24 hours and
6 and 5 at 48 hours. Two patients complained temporary
numbness around the operated area, which regressedwithin
2 and 5 days, respectively.
Healing time varied in a range from 10 to 13 days, with a
mean of 11.89 days and a standard deviation of 1.87. Only 2
patients required a period of regeneration of 20 days, while 3
patients reported complete repair within 7 days.
The procedure with the higher rate of application had
been the exeresis of ﬁbromas (26.08%) (►Fig. 3), followed by
removal of papillomas (16.30%) and removal (16.30%) and
vaporization (15.21%) of leukoplakias (►Table 2). Analysis
revealed that the most treated area was the tongue (29.67%),
followed by cheek mucosa (18.68%) and hard palate (12.09%)
(►Table 5). We elaborated our data and discovered that most
of leukoplakias (37.14%) have been shown in the tongue,
25.7% at the cheek mucosa. Gum and hard palate had a
medium incidence of potentially malignant lesions: both at
14.28%; while lips, soft palate, oral ﬂoor, and other sites
showed a nonrelevant incidence of leukoplakias.
Considering only specimens sent to surgical pathology
evaluation, we had a correlation of 94.8% between clinical
diagnosis and anatomopathological results: 4 lesions proved
to have different nature than we expected from clinical
evaluation. Three patients with a clinical diagnosis of pseu-
doﬁbroma were indeed diagnosed respectively with a cis-
toadenoma, a verrucous proliferative hyperplasia, and a
hyperkeratosis, while a traumatic ulcer proved to be an
inﬁltrating squamous cell carcinoma.
Histological results faithfully replicated clinical diagnosis,
despite a little incongruence of percentage: ﬁbromas repre-
sented 30% of the samples, papillomas 21.43%, and verrucous
proliferative hyperplasias characterized 15.71% of the results
(►Table 6).
Discussion
Several studies discussed the competencies of laser technol-
ogies for OLs, as the development of this technique is moving
toward a painless and bloodless oral surgery.2–4 Our work
sustains this thesis and conﬁrms CO2 laser as a valid option
for treatment of OLs as biopsy, vaporization, or removal.
Table 5 Summary of histological exams of the samples
collected with biopsies and removals
Histological results N %
Traumatic ﬁbroma 21 30.00
Papilloma 15 21.43
Hyperplasia 11 15.71
Granuloma 4 5.71
High grade dysplasia 3 4.29
Low grade dysplasia 3 4.29
Hyperkeratosis with
orthokeratosis/parakeratosis
3 4.29
Ulcer 3 4.29
Inﬁltrating squamous cell carcinoma 1 1.43
In situ carcinoma 1 1.43
Actinic cheilitis 1 1.43
Acanthosis 1 1.43
Cistoadenoma 1 1.43
Venous malformation 1 1.43
Mucocele of minor salivary glands 1 1.43
Total 70 100.00
Table 6 Setting of Lumenis CO2 laser parameters
Setting laser
parameters
Exeresis – Biopsy Vaporization
Wave Continuous Pulsed (0.49 s of
interpulses pause)
Power 4 W 6W
Length 1 mm 3–5 mm
Depth n/a 1 mm
Beam shape Spot Round/square
according to local
anatomy
Scanner
program
Cutting laser for
general surgery
Feather touch/Silk
touch for aesthetic
surgery
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Comparing to others’ works shown in the literature, ours
focused on an overall analysis of laser application on out-
patients’ oral surgery. Moreover, extending the review to
different types of lesions among the benign ones, like granu-
lomas, ﬁbromas, or papillomas, and the potentially malignant
ones, as leukoplakias, allows to provide a way of comparison
not only of results but also of the speciﬁc details of laser
techniques that are employed. Laser settings are indeed an
almost neglected aspect into the specialized literature, which
fails in providing speciﬁc information over this kind of proce-
dure. Clarifying the parameters and methods of laser tech-
nique has the purpose of furnishing a basis for anyone who
approaches for theﬁrst time this kind of surgery, but it is also a
benchmark for comparison between wiser surgeons already
familiar with this practice. Although our works lacks in terms
of novel ﬁndings, our article covers a signiﬁcant gap in the
literature, providing a sort of “beginners’ guide” for laser
surgery, helping newcomers to this technique and providing
a reference for treatment options in a solid patients series.
Manyworks also investigated bleeding resulting from CO2
laser procedures: Goodson et al calculated a 4.87% of bleed-
ing as complication of laser CO2 treatment of cancers and
precancerous OLs.10 Our evaluationmatched this datawith a
5.12% of bleeding cases after procedure.
A study investigated recurrences of oral potentially ma-
lignant disorders over 773 laser procedures: 9% of them
showed persistent disease, andmost of themwere verrucous
leukoplakias. Unexpected oral squamous cell carcinoma was
detected in 12%, while 12% evolved into malignancies. An-
other article registered 19.5% of recurrences in dysplastic
lesions, and 10.4% of malignant progression in a mean of 6.4
years’ follow-up.9,11 A retrospective review of 65 laser-
treated leukoplakias found 33.8% of relapses and 15.4% of
progression rate along 15 months.8
Fig. 1 The picture shows a leukoplakia removal at the ﬂoor of mouth by carbon dioxide (CO2) laser. (A) Lesion before removal. (B) Lesion just
after removal. (C) Lesion 3 weeks after removal.
Fig. 2 The picture shows a leukoplakia vaporization on soft palate by carbon dioxide (CO2) laser. (A) Lesion before vaporization. (B) Lesion just
after vaporization. (C) Lesion 3 weeks after vaporization.
Fig. 3 Fibroma removal on gingival surface by carbon dioxide (CO2) laser. (A) Lesion before removal. (B) Lesion just after removal. (C) Lesion
3 weeks after removal.
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In our group,we identiﬁed 3 relapses over 89procedures on
benignandpotentiallymalignant lesions; recurrencesoccurred
in only leukoplakia formations, demonstrating a rate of 13.63%
of potentially malignant lesions recurrence. Two of themwere
at the tongue (66.6%), and one was at hard palate (33.3%).
CO2 laser has been widely explored and compared with
other surgery methods like conventional scalpel. A recent
study found CO2 surgery as a better technique for intra-
operative hemostasis and reduced scarring; there were not
any signiﬁcant differences in terms of postoperative pain and
swelling.12 Natekar et al evaluated differences between CO2
laser, diode laser, and cryosurgery, and found lasermethods to
bepainlessandwithoutanyswellingor thermaldamage,while
cryosurgery recorded 30% of scar formation, 40% of swelling,
and a higher pain score.4However, therewas a total absence of
bleeding in cryosurgery group, while the CO2 and diode laser
surgery groups showed clinically negligible bleeding tenden-
cies. Another work conﬁrmed the advantage of CO2 laser over
cold knife procedure in terms of pain and swelling.13 All of
these procedures required a following hemostasis.
Several authors agree that hystological dysplasia’s degree
isn’t a predictor of recurrence or malignant transformation
for OLs. Therefore, in literature it’s still debated whether to
routinely manage these lesions with a surgical approach or
not.14
It has to be noted also that our sample reports a very small
percentage of unexpected incidence of squamous carcino-
mas compared with recent literature reports15 (1.43% vs.
12%). This striking differences is most probably due to our
choice of treating as outpatient cases only patientswith none
to negligible chances of malignancy or patients with ex-
tremely small lesions (as in the case of the only in situ
carcinoma we treated in this series). Choosing to manage
with CO2 laser all kind of lesions, irrespectively of their
malignancy risk, might therefore determine a higher number
of unexpected carcinomas.
Several authors also investigated outcomes in termof pain
and healing time. López-Jornet et al found that pain and
swelling reported by patients was greater with the cold knife
than with the CO2 laser.13 While Tambuwala et al found a
nonstatistically signiﬁcant difference between pain occurred
by CO2 laser and scalpel; the former set at 2.2 points on VAS
score 1 day after surgery, and 1.2 two days postoperatively.12
Another work on pediatric laser treatments reported a score
of 0 on VAS scale 1 day after treatment in 86.8% of treated
children.16 They also conﬁrmed the literature’s ﬁndings of
approximately 2 weeks’ healing time for this kind of proce-
dure. Other researchers showed a longer time of recovery,
stated at 3 weeks.17,18We sustained former thesis showing a
mean of 2.5 on VAS scale after 24 hours, a value of 2 after 48
hours, and 0 points 7 days after surgery. The average of
healing time was in a range from 10 to 13 days, further
conﬁrming the best literature data currently available on CO2
laser surgery, also once again on a wider range of lesions.
Another critical point of laser therapy is about the thermal
damage that itmight cause onperi-incisionalmargins during
a biopsy, affecting the histopathological features and creat-
ing doubts about diagnosis.19 Many studies focused on this
topic: Rizoiu et al showed no differences in the histology
among peri-incisional margins of samples excised by laser
and by scalpel; Romeo et al demonstrated in two articles
how, even if lasers caused slight alterations in the taken
tissue margins, no one of Er:YAG, Nd:YAG, Er-Cr:YSGG, and
diode laser compromised the histological evaluation.19–21
Even biopsies of suspicious lesions should not worry about
the thermal effects on peripheral margins: they do not affect
the analysis of cellular inﬁltration in the adjacent tissues and
permit to establish the real cancer size.
Our study reﬂects those ﬁnding, though it is built on a
relatively limited case series and it ismade on a retrospective
review, which does not allow us to pursuit a long-term
follow-up or a standardization of parameters’ collection.
Besides, the results could not have been compared with a
control group of scalpel excision or with other surgical lasers.
We also investigated the effect of vaporization on oral
premalignant lesions, as we performed 9 vaporizations on
leukoplakias and lichen planus which did not show any
relapse, 3 procedures of removal and vaporization in the
same session, and 2 vaporized lesions which evinced a recur-
rence. The rate of relapse among vaporizations has been13.3%.
On the other hand, we performed 11 laser excisions over
leukoplakias, where we had a relapse on only one case (9%).
A study from Brouns et al assessed the annual recurrence rate
among 35 leukoplakias’ vaporizations at 8%, and a malignant
transformationrateat3%.22Another studyevaluated the riskof
early leukoplakia recurrence within 3 months following CO2
laser removal varying by clinical characteristics including
lesion size, site, and accessibility of margins. It came out
how poor accessibility of the lesion margins is a predictor
for early recurrence.23 Finally, Del Corso et almade a compari-
son between laser evaporations and laser excision for the
treatment of oral leukoplakias: they reported no signiﬁcant
differences for recurrences; however, CO2 excision revealed
statistically better results with the nonhomogeneous OLs and
OLs with mild dysplasia.24
Conclusion
Despite the above described limitations, this work permitted
to highlight strongly positive outcomes on outpatients’ laser
surgery for oral lesions treatment. Aside from the clinical
results and the low level of complications that we observed,
whatmostly stands out is theﬂexibility of laser as a complete
device for the management of all kinds of lesions, merging
the properties of removal technique with those of the
vaporization, even in the same surgery session.
Conﬂict of Interest
None.
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